Physician profile
Jane Choi
NPI 1336601384
$2,423.82
in general payments reported to CMS, 2019-2025
30 companies · $18.33 in 2025
The $18.33 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,139 · 2022: $838 · 2023: $378 · 2024: $49.42 · 2025: $18.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.12 | 2021-2023 | |
| Pfizer INC. | $313.25 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $209.11 | 2021-2023 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $128.88 | 2021-2023 | Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $128.33 | 2022 | |
| Lilly USA, LLC | $121.47 | 2022-2023 | Mounjaro |
| Almatica Pharma LLC | $93.96 | 2021 | |
| Novo Nordisk INC | $91.08 | 2021-2023 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $91.08 | 2021-2023 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $87.80 | 2021-2022 | |
| Abbott Laboratories | $83.96 | 2023-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $76.67 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.31 | 2022 | |
| Novartis Pharmaceuticals Corporation | $67.28 | 2021-2022 | |
| Biofire Diagnostics, LLC | $58.67 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $45.55 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $44.76 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $29.41 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.52 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.16 | 2022 | |
| Daiichi Sankyo INC. | $22.31 | 2021 | |
| Merck Sharp & Dohme LLC | $19.91 | 2021 | |
| Genentech USA, INC. | $19.86 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.74 | 2021 | |
| Exact Sciences Corporation | $17.95 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $17.90 | 2021 | |
| Grifols USA, LLC | $15.06 | 2021 | |
| Inogen, INC. | $13.85 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Molnlycke Health Care US, LLC | $12.85 | 2021 | |
| Ibsa Pharma INC. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.